Pages that link to "Q56444948"
Jump to navigation
Jump to search
The following pages link to Hans Jørgen Nielsen (Q56444948):
Displaying 50 items.
- Non-synonymous polymorphisms in the FCN1 gene determine ligand-binding ability and serum levels of M-ficolin (Q21133812) (← links)
- High levels of microRNA-21 in the stroma of colorectal cancers predict short disease-free survival in stage II colon cancer patients (Q24569637) (← links)
- Assessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer (Q27852685) (← links)
- Cysteine proteinase inhibitors stefin A, stefin B, and cystatin C in sera from patients with colorectal cancer: relation to prognosis (Q28145435) (← links)
- High serum YKL-40 level after surgery for colorectal carcinoma is related to short survival (Q28215091) (← links)
- Rapid and individual-specific glycoprofiling of the low abundance N-glycosylated protein tissue inhibitor of metalloproteinases-1. (Q33268341) (← links)
- Investigation of tissue inhibitor of metalloproteinases 1 in plasma from colorectal cancer patients and blood donors by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry. (Q33286723) (← links)
- Changes in plasma IL-6, plasma VEGF and serum YKL-40 during Treatment with Etanercept and Methotrexate or Etanercept alone in Patients with Active Rheumatoid Arthritis Despite Methotrexate Therapy (Q33552038) (← links)
- An explorative analysis of ERCC1-19q13 copy number aberrations in a chemonaive stage III colorectal cancer cohort (Q33589368) (← links)
- Prognostic and predictive value of cathepsin X in serum from colorectal cancer patients (Q33612332) (← links)
- P1 plasmid segregation: accurate redistribution by dynamic plasmid pairing and separation. (Q33648662) (← links)
- Sessile serrated lesion and its borderline variant - Variables with impact on recorded data (Q33934766) (← links)
- Translation, adaptation, validation and performance of the American Weight Efficacy Lifestyle Questionnaire Short Form (WEL-SF) to a Norwegian version: a cross-sectional study (Q34260165) (← links)
- Measuring ERCC1 protein expression in cancer specimens: validation of a novel antibody (Q34408771) (← links)
- Data fusion in metabolomic cancer diagnostics (Q34555587) (← links)
- National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers (Q34601116) (← links)
- VEGF and tumour angiogenesis. Impact of surgery, wound healing, inflammation and blood transfusion (Q34624350) (← links)
- Mechanisms of topoisomerase I (TOP1) gene copy number increase in a stage III colorectal cancer patient cohort (Q34663849) (← links)
- Urokinase-type plasminogen activator receptor (uPAR) on tumor-associated macrophages is a marker of poor prognosis in colorectal cancer (Q35000422) (← links)
- The role of tissue factor in colorectal cancer. (Q35150635) (← links)
- Screening for colorectal cancer: possible improvements by risk assessment evaluation? (Q35496548) (← links)
- Performance of the colorectal cancer screening marker Sept9 is influenced by age, diabetes and arthritis: a nested case-control study (Q35826444) (← links)
- Haemostatic alterations in colorectal cancer: perspectives for future treatment (Q35964237) (← links)
- Blood-based Biomarkers at Large Bowel Endoscopy and Prediction of Future Malignancies (Q36207546) (← links)
- Dynamics of Escherichia coli chromosome segregation during multifork replication (Q36315382) (← links)
- Cathepsin X in serum from patients with colorectal cancer: relation to prognosis (Q36322404) (← links)
- Plasma levels of OLFM4 in normals and patients with gastrointestinal cancer (Q36394711) (← links)
- Phospho-ERK1/2 levels in cancer cell nuclei predict responsiveness to radiochemotherapy of rectal adenocarcinoma (Q36544089) (← links)
- Serum YKL-40 and colorectal cancer. (Q36619099) (← links)
- Prognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinoma (Q36643878) (← links)
- Banking of biological fluids for studies of disease-associated protein biomarkers (Q36919974) (← links)
- Plasma tissue inhibitor of metalloproteinases-1 (TIMP-1): a novel biological marker in the detection of primary colorectal cancer. Protocol outlines of the Danish-Australian endoscopy study group on colorectal cancer detection (Q37068854) (← links)
- Energy intake, nutritional status and weight reduction in patients one year after laparoscopic sleeve gastrectomy (Q37068974) (← links)
- Investigations on collectin liver 1. (Q37095461) (← links)
- Biology and potential clinical implications of tissue inhibitor of metalloproteinases-1 in colorectal cancer treatment (Q37201570) (← links)
- miRNA profiling of circulating EpCAM( ) extracellular vesicles: promising biomarkers of colorectal cancer (Q37218300) (← links)
- Immunotherapy in colorectal cancer (Q37280829) (← links)
- Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers. (Q37290410) (← links)
- Detection of serological biomarkers by proximity extension assay for detection of colorectal neoplasias in symptomatic individuals (Q37308179) (← links)
- The multifork Escherichia coli chromosome is a self-duplicating and self-segregating thermodynamic ring polymer. (Q37488740) (← links)
- Positron emission tomography/computed tomography and biomarkers for early treatment response evaluation in metastatic colon cancer (Q37589065) (← links)
- Positron emission tomography/computed tomography for optimized colon cancer staging and follow up. (Q37641478) (← links)
- TIMP-1 is under regulation of the EGF signaling axis and promotes an aggressive phenotype in KRAS-mutated colorectal cancer cells: a potential novel approach to the treatment of metastatic colorectal cancer (Q37644878) (← links)
- Determinants of recurrence after intended curative resection for colorectal cancer (Q38265049) (← links)
- Topoisomerase-1 and -2A gene copy numbers are elevated in mismatch repair-proficient colorectal cancers (Q38387376) (← links)
- Evaluation of Sample Handling in Relation to Levels of Tissue Inhibitor of Metalloproteinases-1 Measured in Blood by Immunoassay (Q38450574) (← links)
- Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer (Q38643673) (← links)
- TOP1gene copy numbers in colorectal cancer samples and cell lines and their association toin vitrodrug sensitivity (Q39428021) (← links)
- Topoisomerase 1(TOP1) gene copy number in stage III colorectal cancer patients and its relation to prognosis (Q39528312) (← links)
- Directions for further improvements of treatment of metastatic colorectal cancer (Q39674303) (← links)